Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
08 April 2022 - 09:36PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April, 2022
Commission file number: 001-37891
AC IMMUNE SA
(Exact Name of Registrant as Specified in Its Charter)
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ☐
No ☒
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ☐
No ☒
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
AC IMMUNE SA |
|
|
|
|
|
|
|
|
|
By: |
/s/ Andrea Pfeifer |
|
|
Name: |
Andrea Pfeifer |
|
|
Title: |
Chief Executive Officer |
|
|
|
|
|
|
|
|
|
By: |
/s/ Joerg Hornstein |
|
|
Name: |
Joerg Hornstein |
|
|
Title: |
Chief Financial Officer |
Date: April
8, 2022
EXHIBIT INDEX
Exhibit
Number |
Description |
99.1 |
Press Release dated April 8, 2022 |
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Feb 2024 to Mar 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Mar 2023 to Mar 2024